Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Diffusion Pharmaceuticals Inc is a biotechnology business based in the US. Diffusion Pharmaceuticals shares (DFFN) are listed on the NASDAQ and all prices are listed in US Dollars. Diffusion Pharmaceuticals employs 12 staff and has a market cap (total outstanding shares value) of 0.00.
|Latest market close||$0.45|
|52-week range||$0.45 - $1.85|
|50-day moving average||$0.51|
|200-day moving average||$0.62|
|Wall St. target price||$2.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.22|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-5.90%|
|1 month (2021-09-24)||-10.87%|
|3 months (2021-07-23)||-18.18%|
|6 months (2021-04-23)||-38.36%|
|1 year (2020-10-23)||-48.27%|
|2 years (2019-10-24)||-61.54%|
|3 years (2018-10-24)||12.50%|
|5 years (2016-10-21)||6|
|Gross profit TTM||$0|
|Return on assets TTM||-25.19%|
|Return on equity TTM||-40.76%|
|Market capitalisation||$45.4 million|
TTM: trailing 12 months
There are currently 781,660 Diffusion Pharmaceuticals shares held short by investors – that's known as Diffusion Pharmaceuticals's "short interest". This figure is 20.9% down from 988,610 last month.
There are a few different ways that this level of interest in shorting Diffusion Pharmaceuticals shares can be evaluated.
Diffusion Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Diffusion Pharmaceuticals shares currently shorted divided by the average quantity of Diffusion Pharmaceuticals shares traded daily (recently around 1.1 million). Diffusion Pharmaceuticals's SIR currently stands at 0.69. In other words for every 100,000 Diffusion Pharmaceuticals shares traded daily on the market, roughly 690 shares are currently held short.
However Diffusion Pharmaceuticals's short interest can also be evaluated against the total number of Diffusion Pharmaceuticals shares, or, against the total number of tradable Diffusion Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Diffusion Pharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Diffusion Pharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.0077% of the tradable shares (for every 100,000 tradable Diffusion Pharmaceuticals shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Diffusion Pharmaceuticals.
Find out more about how you can short Diffusion Pharmaceuticals stock.
We're not expecting Diffusion Pharmaceuticals to pay a dividend over the next 12 months.
Diffusion Pharmaceuticals's shares were split on a 1:15 basis on 13 December 2018. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Diffusion Pharmaceuticals shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Diffusion Pharmaceuticals shares which in turn could have impacted Diffusion Pharmaceuticals's share price.
Over the last 12 months, Diffusion Pharmaceuticals's shares have ranged in value from as little as $0.45 up to $1.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Diffusion Pharmaceuticals's is 1.5429. This would suggest that Diffusion Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Diffusion Pharmaceuticals Inc. , a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company is also developing DFN-529, a phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway inhibitor. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.